Conning Portfolio holdings
Conning manages money mainly for insurance companies and pension plans, mostly in bonds and stocks. William S. Conning founded the firm in 1912 to give investment advice to high-net-worth individuals, and it began managing investments for insurers in 1983. Conning has grown by buying majority stakes in specialist managers, including Octagon Credit Investors, which focuses on loans and high yield bonds, in 2016, and the emerging markets debt manager Global Evolution, in which it became majority owner in 2020. It is part of Generali Investments, and its controlling shareholder is Generali Investments Holding, based in Italy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
IBM
IBM
|
+$15.5M |
| 2 |
Pfizer
PFE
|
+$15.1M |
| 3 |
Sysco
SYY
|
+$14.7M |
| 4 |
Analog Devices
ADI
|
+$14.6M |
| 5 |
Abbott
ABT
|
+$14.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$12.4M |
| 2 |
Applied Materials
AMAT
|
+$12M |
| 3 |
Northrop Grumman
NOC
|
+$11.9M |
| 4 |
3M
MMM
|
+$11.4M |
| 5 |
Medtronic
MDT
|
+$11.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 18.01% |
| 2 | Consumer Staples | 13.14% |
| 3 | Industrials | 12.74% |
| 4 | Technology | 12.19% |
| 5 | Healthcare | 12.01% |
Similar funds
Conning's Q4 2013 Portfolio in Review
As of Q4 2013, Conning held 551 positions worth $1.61B, up 25% from $1.3B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Conning deployed $130M of net new capital in Q4 2013, opening 53 new positions and adding to 373 existing holdings. Its largest new stake was NEXTERA ENERGY INC EQUITY UNIT: 165,000 shares worth $8.28M.
By sector, the portfolio is most concentrated in Miscellaneous at 18% of assets, down from 21% a quarter earlier, followed by Consumer Staples and Industrials.
On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $12.4M trimmed.
- Conning's largest Q4 2013 buy was NEXTERA ENERGY INC EQUITY UNIT: 165,000 shares worth $8.28M.
- Conning added most to IBM in Q4 2013, an estimated $15.5M increase.
- Conning's biggest Q4 2013 reduction was Bristol-Myers Squibb, cutting an estimated $12.4M.
- Conning fully exited NYSE EURONEXT INC in Q4 2013, selling an estimated $533K.
- Conning's ten largest holdings make up 16% of its $1.61B portfolio in Q4 2013.
- Conning opened 53 new positions and closed 4 in Q4 2013.
- Conning's portfolio value rose 25% quarter-over-quarter to $1.61B.
Based on Conning's 13F filing for Q4 2013, filed 4 Feb 2014.